发明名称 Fatty acid treatment for cardiac patients
摘要 A method of treating patients in need of treatment for a cardiac disorder has been found which comprises administering to the patient a seven carbon fatty acid compound or derivative thereof, wherein the compound or derivative thereof is able to readily enter the mitochondrion without special transport enzymes. A dietary formulation suitable for treatment of heart tissue in cardiac or surgical patients has been found which comprises a seven-carbon fatty acid chain, wherein the seven-carbon fatty acid chain is characterized by the ability to transverse the inner mitochondrial membrane by a transport mechanism which does not require carnitine palmitoyltransferase I, carnitine palmitoyltransferase II, or carnitine/acylcarnitine translocase and the ability to undergo mitochondrial β-oxidation, and wherein the compound is selected from the group consisting of n-heptanoic acid or a derivative thereof, a triglyceride comprising n-heptanoic acid or a derivative thereof, and triheptanoin or a derivative thereof.
申请公布号 US9402822(B2) 申请公布日期 2016.08.02
申请号 US201414523810 申请日期 2014.10.24
申请人 Baylor Research Institute 发明人 Roe Charles R.
分类号 A61K31/194;A61K31/19;A61K31/20;A61K31/23 主分类号 A61K31/194
代理机构 Cooley LLP 代理人 Cooley LLP
主权项 1. A composition comprising a seven carbon fatty acid source in a dosage unit, wherein the dosage unit comprises at least 15 grams of the seven carbon fatty acid source and wherein the composition is provided in an amount suitable for providing 15% to 40% of the daily dietary calories of a human.
地址 Dallas TX US